Pensa F - Search Results

1

EGF in breast cyst fluid: relationships with intracystic androgens, estradiol and progesterone.

Boccardo F, Torrisi R, Zanardi S, Valenti G, Pensa F, De Franchis V, Barreca A, Ferraro P, Minuto F. Boccardo F, et al. Among authors: pensa f. Int J Cancer. 1991 Feb 20;47(4):523-6. doi: 10.1002/ijc.2910470409. Int J Cancer. 1991. PMID: 1995483

2

Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.

Torrisi R, Zanardi S, Pensa F, Valenti G, De Franchis V, Nicolo G, Barreca A, Minuto F, Boccardo F. Torrisi R, et al. Among authors: pensa f. Breast Cancer Res Treat. 1995 Mar;33(3):219-24. doi: 10.1007/BF00665946. Breast Cancer Res Treat. 1995. PMID: 7749149

3

Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content.

Zanardi S, Pensa F, Torrisi R, De Franchis V, Barreca A, Minuto F, Boccardo F. Zanardi S, et al. Among authors: pensa f. Int J Cancer. 1994 Dec 15;59(6):725-7. doi: 10.1002/ijc.2910590602. Int J Cancer. 1994. PMID: 7989108

4

Presence and distribution of growth factors in breast cyst fluid.

Zanardi S, Pensa F, Torrisi R, de Franchis V, Barreca A, Minuto F, Boccardo F. Zanardi S, et al. Among authors: pensa f. Ann N Y Acad Sci. 1996 Apr 30;784:542-9. doi: 10.1111/j.1749-6632.1996.tb16278.x. Ann N Y Acad Sci. 1996. PMID: 8651614 Review. No abstract available.

5

The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.

Torrisi R, Pensa F, Orengo MA, Catsafados E, Ponzani P, Boccardo F, Costa A, Decensi A. Torrisi R, et al. Among authors: pensa f. Cancer Res. 1993 Oct 15;53(20):4769-71. Cancer Res. 1993. PMID: 8402658 Clinical Trial.

6

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.

Torrisi R, Parodi S, Fontana V, Pensa F, Casella C, Barreca A, De Palo G, Costa A, Decensi A. Torrisi R, et al. Among authors: pensa f. Int J Cancer. 1998 Jun 10;76(6):787-90. doi: 10.1002/(sici)1097-0215(19980610)76:6<787::aid-ijc3>3.0.co;2-u. Int J Cancer. 1998. PMID: 9626341

7

Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trial.

Decensi A, Torrisi R, Fontana V, Barreca A, Ponzani P, Pensa F, Parodi S, Costa A. Decensi A, et al. Among authors: pensa f. Eur J Cancer. 1998 Jun;34(7):999-1003. doi: 10.1016/s0959-8049(97)10170-8. Eur J Cancer. 1998. PMID: 9849446 Clinical Trial.

8

Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion.

Decensi A, Torrisi R, Marroni P, Pensa F, Padovani P, Boccardo F. Decensi A, et al. Among authors: pensa f. Prostate. 1994;24(1):17-23. doi: 10.1002/pros.2990240106. Prostate. 1994. PMID: 8290386 Clinical Trial.

9

The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1.

Torrisi R, Pensa F, Fontana V, Costa A, Decensi A. Torrisi R, et al. Among authors: pensa f. Eur J Cancer. 1995;31A(3):420-1. doi: 10.1016/0959-8049(94)00524-9. Eur J Cancer. 1995. PMID: 7786612 No abstract available.

10

Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status.

Favoni RE, de Cupis A, Perrotta A, Sforzini S, Amoroso D, Pensa F, Miglietta L. Favoni RE, et al. Among authors: pensa f. J Cancer Res Clin Oncol. 1995;121(11):674-82. doi: 10.1007/BF01218526. J Cancer Res Clin Oncol. 1995. PMID: 7593132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters